Able to give written informed consent and comply with all study visits and procedures.
Patients and physicians must be willing to comply with treatment assignment:
The subject is willing and able to abide by the protocol
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations
Patients must be deemed able to comply with the treatment plan and follow-up schedule
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Participant is willing to comply with the protocol for the duration of the study, and undergo treatment and scheduled visits and examinations including follow up
Is willing and able to remain confined in the study unit for the entire duration of each treatment period and comply with restrictions related to food, drink and medications
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study
Subject has the willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Willing to comply with clinical trial instructions and requirements, including mandatory biopsies
Ability to comply with the study protocol, in the investigator's judgment
Patients must be deemed able to comply with the treatment plan and follow-up schedule
Ability and willingness to comply with the study protocol for the duration of the study and with follow-up procedures.
COHORT 1: As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
COHORT 2: As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
Ability to understand and the willingness to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study, including disease assessment by MRI (or CT), as confirmed by signing a written informed consent document
Ability to comply with study procedures in the Investigator's opinion
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Must be able to comply with the treatment plan and follow-up schedule
Willing and able to comply with all aspects of the protocol
Subject should be able to provide written informed consent, comply with protocol visits and procedures, be able to take oral medication, and not have any active infection or comorbidity that would interfere with therapy.
Patients must be willing and able to complete all study procedures
Willingness and ability to comply with scheduled visits and study procedures
Patient able and willing to comply with study procedures as per protocol
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.
Ability to understand and the willingness to sign a written informed consent document. Patients must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.
Willingness and ability to comply with scheduled visits, drug administration plan, protocol-specified laboratory tests, other study procedures, and study restrictions.
Psychiatric condition making the patient unlikely to comply with protocol therapy, required tests and follow-up.
Reliable and willing to make themselves available for the duration of the study and are willing to follow study-specific procedures.
Ability to comply with study visits, treatment, procedures, PK and PD sample collection, and required study follow-up
Willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations, including follow-up
Be willing to comply with clinical trial instructions and requirements, including mandatory biopsies.
Patients >= 18 years must be willing to comply with the mandatory biopsies.
Patient must be willing and able to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures.
Ability to understand and the willingness to sign a written informed consent document; subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Ability to comply with the study protocol, in the investigator's judgment
Willingness and ability to comply with study and follow-up procedures.
In the investigatorâ€™s judgment, the subject is unlikely to complete all protocol-required study visits or procedures, including follow-up visits, or comply with the study requirements for participation
Participant must be willing and able to comply with all aspects of the protocol
Willingness and ability to comply with the study scheduled visits, treatment plans, laboratory tests and other procedures
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Ability to understand and the willingness to sign a written informed consent document; patients must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations
Willingness and ability to comply with scheduled visits (including geographical distance), treatment plans, laboratory tests, and other study procedures.
Willingness and ability to comply with study and follow-up procedures
Ability to comply with the study protocol, in the investigator's judgment
Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required procedures.
Ability to understand and the willingness to sign a written informed consent document and comply with the study scheduled visits, treatment plans, laboratory tests and other procedures.
Subject is willing and able to comply with scheduled visits, treatment plans, laboratory tests and other procedures (including bone marrow assessments).
As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Be willing and able to comply with scheduled visits, the treatment plan, imaging and laboratory tests
Willing and able to comply with the scheduled visits
Limitation of the patient's ability to comply with the treatment or follow-up protocol.
Ability to comply with the protocol
Subjects likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge
Ability to attend all scheduled study visits
Patients who cannot comply with protocol requirements including clinic visits for intravenous infusions and birth control measures may not be enrolled.
Willing and able to comply with scheduled visits, treatment plans, laboratory tests and procedures.
Patients must be willing and able to comply with scheduled visits, treatment plan and laboratory tests
Willingness and ability to understand the nature of this study and to comply with the study and follow-up procedures.
Subject is able to comply with study procedures and follow-up examinations
Willing and able to comply with the protocol, including follow-up visits and examinations
Patients must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study
Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
Must be willing and able to accept at least three leukapheresis procedures
Patient must be able and willing to comply with study procedures as per protocol
Willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations with follow up.
Subjects with a medical or psychological impediment that would impair the ability of the subject to receive therapy per protocol or impact ability to comply with the protocol or protocol-required visits and procedures
Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan, procedures, and laboratory testing
Willingness and ability to comply with study procedures and follow-up examination
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study, including disease assessment by magnetic resonance imaging (MRI).
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.
Willingness to give consent and comply with all study-related evaluations and treatment schedule; and
Signed informed consent and willingness/ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Able to understand the purpose and risks of the study; willing and able to adhere to scheduled visits, treatment plans, laboratory tests, and other study evaluations and procedures, and provide written informed consent
Participants must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study
Willingness and ability of the subject to comply with study activities.
Willingness and ability of the subject to comply with scheduled visits, drug administration plan, protocol-specified laboratory tests, other study procedures (including all bone marrow biopsy/aspirations and radiographic studies), and study restrictions.
Be willing to comply with treatment protocol
Ability to comply with the treatment schedule
Judgment by the investigator that the patient should not participate in the study if the patient is unlikely to comply with study procedures, restrictions and requirement
Patient must be willing to comply with all aspects of the protocol including completing the drug diary
Ability to comply with the study protocol, in the investigator's judgment
In the investigators judgment, the subject is unlikely to complete all protocol-required study visits or procedures, including follow-up visits, or comply with the study requirements for participation
Willingness and ability to comply with the trial and follow-up procedures.
Willingness and ability to comply with scheduled visit, treatment plans, laboratory tests, and other procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Ability and willingness to comply with all study requirements, including scheduled visits, treatment plans, laboratory tests, and other study-related procedures
Ability to comply with all study procedures and willingness to remain supine for 120 minutes during imaging
Subjects deemed unable to comply with study and/or follow-up procedures.
Ability to comply with the protocol
Stated willingness to comply with study procedures and duration.
Willing to travel to the NIH for follow-up visits
Patient is able and willing to comply with protocol and study procedures for the duration of the study including undergoing treatment and scheduled visits and examinations including follow-up visits
Willing and able to comply with the protocol, including follow-up visits and examinations
Willingness and ability to comply with the study scheduled visits, treatment plans, laboratory tests and other procedures
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
As determined by the enrolling physician or protocol designee, willingness and ability of the subject to understand and comply with study procedures
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
Willing and able to provide a signed and dated informed consent, comply with the study plan, follow up visits and phone calls
Be willing and have the ability to comply with scheduled visits (including geographical proximity), treatment plans, laboratory tests, and other study procedures
Participants must be willing to comply with all aspects of the protocol.
Must be willing and able to accept at least three leukapheresis procedures
In the investigators judgment, the subject is unlikely to complete all protocol required study visits or procedures, including follow up visits, or comply with the study requirements for participation
Ability to comply with the protocol
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.
be willing and able to comply with study visits and procedures;
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Patients willing to comply with the clinical trial protocol
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Ability to comply with the protocol
Willing and able to give informed consent and comply with all aspects of the protocol
Stated willingness to comply with all study procedures and be available for the duration of the trial
Ability and capacity to comply with the study and follow-up procedures
Patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests and other study procedures.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study
Ability to comply with the protocol.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with scheduled visits, treatment plans, including willingness to take study medication, laboratory tests, and other study procedures
Must understand and be able, willing, and likely to fully comply with study procedures and restrictions.
Willingness and ability to comply with scheduled visits treatment plans, laboratory tests and other study procedures
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedure
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willing and able to complete study procedures within the study timelines
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study
Be willing to comply with treatment protocol
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including biopsies and follow up.
Be willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
CELL PROCUREMENT: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures
LYMPHODEPLETION: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures
iC9-CAR19 CELL INFUSION: As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and biopsies as detailed in the protocol.
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study
Subject likely to not be available to complete all protocol required study visits or procedures to the best of the subject and investigator's knowledge
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty
Patients must be willing to travel to the study site for follow-up visits
Presence of psychiatric or neurologic disease, or lack of social support that limits patient's ability to comply with the treatment protocol including supportive care, follow-up, and research tests
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willing and able to comply with required scheduled visits and study procedures.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Subject is willing and able to comply with all protocol required visits and assessments.
Patients must be willing and able to comply with scheduled visits, treatment and assessments
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Must be willing and able to accept two leukapheresis procedures
PHASE I: Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with scheduled visits, treatment plans, including willingness to take axitinib, laboratory tests, and other study procedures
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures
Be able and willing to comply with study visits and procedures
Patients must express willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Patients must be willing and able to comply with scheduled visits, treatment plan, and laboratory tests and accessible for follow-up.
Able to give written informed consent and comply with all study visits and procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Patients who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Patient must be willing and able to comply with scheduled visits, treatment plan, and laboratory tests
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures.
For the patient or parent/legal guardian to be able to comply with treatment plan, study procedures and follow-up examinations
Ability to understand and willingness for follow-up visits.
Willingness and ability to comply with all study procedures and able to take oral medications
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, imaging studies, and other requirements of the study
Ability to understand and the willingness to sign a written informed consent document and comply with the study scheduled visits, treatment plans, laboratory tests and other procedures
The subject is willing and able to comply with the protocol, and agrees to return to the hospital for follow?up visits and examination
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing
Subject must be able to provide written informed consent, comply with protocol visits and procedures, and take oral medication, and does not have any active infection or comorbidity that would interfere with therapy
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Willing to comply with scheduled visits and procedures
Ability to comply with the treatment schedule
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with study procedures and follow-up examinations
Be willing and able to comply with scheduled visits, the treatment plan, and laboratory tests
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures
Ability to understand and comply with study procedures for the entire length of the study as determined by the site investigator or protocol designee
Comply with study procedures and site visits
Ability to comply with study visits, treatment, procedures, PK and PD sample collection, and required study follow-up
Be willing and able to comply with this protocol
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willing and able to comply with the protocol, scheduled follow-up, and management of toxicity as judged by the Investigator. Cohort 3B (Combination Expansion): Osteosarcoma subjects who progressed in Cohorts 1 or 2B and opt to receive combination therapy.
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.
Willing and able to comply with all study procedures
Ability to comply with the protocol
Must be willing and able to comply with study
Willing and able to comply with the protocol, including follow-up visits and examinations
Patient is willing to comply with protocol requirements and procedures, and keep scheduled study visits
Subject is able to provide written informed consent, comply with protocol visits and procedures, and take oral medication, and does not have any active infection or comorbidity that would interfere with therapy.
Patients must be capable of giving informed consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing
Ability to comply with study and follow-up procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Participant must be willing to comply with study and/or follow-up procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Patient is willing and able to comply with protocol required assessments and procedures
Be able to comply with study procedures and follow-up examinations
Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing
Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures
Must be willing and able to accept at least two leukapheresis procedures
COHORTS 1 AND 2: HEALTHY VOLUNTEERS: Subjects must participate fully and be willing to comply with the procedures of the protocol
Patients willing and able to comply with the study protocol for the duration of the study
Willing to comply with study procedures
Willingness and ability to comply with scheduled visits, drug administration plan, laboratory tests,\r\nother study procedures, and study restrictions
Able and willing to comply with testing and treatment as outlined in this protocol
Willingness to comply with study guidelines
Subject is willing and able to comply with all protocol required visits and assessments, including biopsy if assigned.
Willing and able to comply with clinic visits and study-related procedures
Patients must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up.
Ability to understand and the willingness to sign a written informed consent document; subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures.
Willing and able to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions including mandatory prophylaxis for Pneumocystis jirovecii pneumonia (PJP)
Must be available during the duration of the study and willing to follow the study procedures
Patient is currently enrolled in a Novartis-sponsored, Oncology Clinical Development & Medical Affairs study receiving imatinib and has fulfilled all their requirements in the parent study. 2.Patient is currently benefiting from the treatment with imatinib, as determined by the investigator. 3. Patient has demonstrated compliance, as assessed by the investigator, with the parent study protocol requirements.4. Willingness and ability to comply with scheduled visits, treatment plans and any other study procedures. 5. Written informed consent obtained prior to enrolling in roll-over study.
Patients who cannot comply with medications
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Patients who are able and willing to give consent and able to attend all study visits
Patient able and willing to comply with study procedures as per protocol
Ability to comply with the protocol procedures (including geographic accessibility)
Patients must be able to comply with the protocol treatments and procedures.
Have the ability to understand and comply with the requirements and follow-up time points of the study
Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty
Subjects who are willing and able to comply with scheduled visits, treatment plans, laboratory tests, and procedures.
223 Subjects likely to not be available to complete all protocol- required study visits or procedures including BM aspirates/biopsies, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.
Willingness and ability to comply with study and follow-up procedures
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations
Willingness to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions; psychological, social, familial or geographical factors that might preclude adequate study participation should be considered
Subject is willing and able to comply with the protocol for the duration of the study
Willingness and ability to comply with study and follow-up procedures.
Willingness and ability to comply with scheduled visits, treatment plans, laboratory and radiographic assessments, and other study procedures, including ability to swallow study drug tablets and long-term follow-up
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and exams including follow up
Patient is able and willing to comply with protocol and study procedures for the duration of the study including undergoing treatment and scheduled visits and examinations including follow-up visits
Subjects is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee
Are able and willing to comply with all study procedures.
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty.
Subject must be willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Able to comply with the protocol, including tissue and blood sampling
Have the willingness and ability to understand the nature of this study and to comply with the study and follow-up procedures.
The subject must be willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.
State willingness to comply with all study procedures and be available for the duration of the trial
Participants must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Patient must be able and willing to comply with study procedures as per protocol
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willingness and ability to comply with scheduled visits, drug administration plan,\n             laboratory tests, other study procedures, and study restrictions
Willingness and ability to comply with scheduled visits, treatment plans, laboratory\n             tests, and other study procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures
Emotional limitations, which the investigator judges could limit the patient's ability to follow up and comply with study procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations
Patients who, for medical or other reasons, are unable to comply with the study procedures
Able and willing to comply with study criteria
Willing and able to comply with all study procedures
Willing and able to comply with study procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests, including biopsies
Willing and able to comply with follow-up schedule
Willingness and ability to consent for self and to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Limitation of the patient's ability to comply with the treatment or to follow-up the protocol.
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty.
Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject's and investigator's knowledge.
Have the willingness and ability to comply with scheduled visit and study procedures.
Ability and willingness to comply with scheduled visits, treatment plan, laboratory assessments and other study procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Patients must comply with the treatment plan and follow-up schedule.
Ability to comply with the study protocol, in the investigatorâ€™s judgment
Limitation of the patient's ability to comply with the treatment or follow-up requirements.
Subject is willing and able to comply with all protocol required visits and assessments, including biopsy if assigned to the MTD expansion cohort;
Participant must be willing and able to comply with all aspects of the protocol.
Willing to comply with study procedures
Be willing and able to comply with all aspects of the protocol
Subjects must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
Must be willing and able to accept two leukapheresis procedures
Is willing to and able to comply with scheduled visits and study procedures.
Willing and able to comply with all aspects of the protocol
Patient is willing and able to give consent and attend all study visits as defined in the protocol
Must be willing and able to accept at least two leukapheresis procedures
Willing and able to comply with all aspects of the treatment protocol
Subjects with a medical or psychological impediment that would impair the ability of the subject to receive therapy per protocol or impact ability to comply with the protocol or protocol-required visits and procedures
Patients must be willing and able to comply with scheduled visits, treatment plan and laboratory tests
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
As determined by the enrolling physician or protocol designee, the subject should be able to understand and comply with study procedures for the entire length of the study
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Signed informed consent and willingness/ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Ability to comply with study procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures
Must be willing and able to comply with study visits and procedures.
Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study
Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty
Patient must be able to give informed consent and comply with the treatment protocol and follow-up plan.
Available for the duration of the study and are willing to follow study-specific procedures.
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures.
Willingness to comply with all study interventions and follow-up procedures
Willing and able to participate in all study related procedures and therapy including swallowing capsules without difficulty
Patients must provide signed, written, informed consent and be willing and able to comply with eligibility requirements, scheduled, visits, and follow-up studies
Subjects must give informed consent and must be willing and able to comply with the scheduled visits, treatment plans, laboratory tests, and other procedures
Patients must be willing to travel to the study site for follow-up visits
The patient is able and willing to comply with all study related procedures
Willingness and ability to comply with study and follow-up procedures.
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Have the willingness and ability to comply with scheduled visits and study procedures.
Subjects deemed unable to comply with study and/or follow-up procedures
Patient must be willing to comply with study procedures
Patients must be willing and able to comply with scheduled visits, treatment plan and laboratory tests
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty.
As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
Be willing and able to comply with the treatment plan, scheduled clinic visits, laboratory and oncological tests and other study procedures
Patients are willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations, and completing PRO instruments.
Ability and willingness to follow the guidelines of the clinical protocol including visits to National Institute of Child Health and Human Development (NICHD) and NCI, Bethesda, Maryland for treatment and follow up visits
Willing and able to comply with clinic visits and study-related procedures
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations.
Is able and willing to follow all study procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Patients must be willing and able to comply with study and/or follow-up procedures
Willing and able to comply with all aspects of the protocol
Willing to travel to the NIH for follow-up visits
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Willing and able to comply with the protocol, including follow-up visits and examinations.
Patients must be able to sign consent and be willing and able to comply with scheduled visits, treatment plan and laboratory testing
Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures outlined in the protocol
Be able to comply with treatment plan, study procedures and follow-up examinations
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
able to comply with all study-related procedures, medication use, and evaluations.
Patient is able to comply with all study procedures including study drug administration, visits and tests
Able to comply with scheduled follow-up and with management of toxicity
Patient must be willing and able to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Able to comply with scheduled follow-up and with management of toxicity.
Subject agrees to comply with follow up visits
Patients must be willing to comply with effective Antiretroviral Therapy.
Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures outlined in the protocol
Subject's willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Ability to comply with study procedures, in the Investigator's opinion
Subject must be willing and able to comply with all aspects of the protocol
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willing and able to understand the nature of this study and to comply with the study and follow-up procedures.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Patients who are not able to comply with study and/or follow up procedures
Ability to understand and the willingness to sign a written informed consent and comply with the study scheduled visits, treatment plans, laboratory tests and other procedures
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations; and
Be willing and have the ability to comply with scheduled visits (including geographical proximity), treatment plans, laboratory tests, and other study procedures
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures
Patient is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Stated willingness of patient to comply with study procedures and reporting requirements.
Be willing to comply with the protocol.
Willingness to comply with scheduled visits, drug administration plan, protocol-specified bone marrow biopsies;
Willing to comply with study procedures and follow-up
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
Participant must be willing to comply with study and/or follow-up procedures
Patients must be willing to comply with study procedures
Willing and able to participate in all required evaluations and procedures in this study protocol including swallowing capsules without difficulty
Be able to comply with study procedures and follow-up examinations
Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
Willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
Willingness and ability to comply with study and followup procedures.
Willingness and ability to comply with study and follow-up procedures
Patients (or guardians/parents) who are able and willing to give consent (and assent where applicable) and able to attend all study visits
Ability to understand and the willingness to sign a written informed consent document and follow the guidelines of the clinical protocol including visits to National Cancer Institute (NCI), Bethesda, Maryland for treatment and follow up visits
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Anticipated non-availability for study visits/procedures
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other study obligations
Be willing and able to comply with the protocol
Willing and able to comply with all aspects of the treatment protocol.
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Ability and willingness to comply with study visits, treatment, testing, and to comply with the protocol, in the investigator's judgment
Patient must be willing and able to comply with the study procedures and visit schedules and must be able to follow verbal and written instructions.
Willing and able to comply with scheduled visits, study assessments and laboratory tests, and other study procedures
Patients must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study.
Willing to give consent and comply with study-related evaluation and treatment schedule; and
Patient able and willing to comply with study procedures as per protocol, including the geriatric assessment at the time of study enrollment
Willingness to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions
Ability to comply with the protocol
Subject must be willing to comply with all procedures and assessments.
Willing and able to comply with scheduled visits, drug administration plan, imaging studies, laboratory tests, other study procedures, and study restrictions including mandatory prophylaxis for pneumocystis jiroveci pneumonia (PJP)
Able and willing to comply with all study procedures.
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other trial procedures
Patient must be willing and able to comply with the protocol for the duration of the study, including attending scheduled visits, examinations, the biopsy procedure, and having their tumor and blood molecularly characterized
Subject should be able to provide written informed consent and comply with protocol visits and procedures.
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Is the subject willing and able to abide by the protocol?
Unwillingness or inability to comply with scheduled visits, drug administration plan, laboratory tests, other study procedures, and study restrictions.
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests and other study procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures, including thrombokinetic studies and platelet function studies
Anticipated non-availability for study visits/procedures.
Are reliable and willing to make themselves available for the duration of the study and are willing to follow study procedures
Reliable and available for the duration of the study and willing to follow study procedures.
Ability and willingness to follow the guidelines of the clinical protocol including visits to NCI, Bethesda, Maryland for treatment and follow up visits
Willing to comply with study procedures and follow-up
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Willing and able to comply with the protocol guidelines for the duration of the study
Willingness and ability to comply with all study procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other procedures
Patient is willing and able to take oral medications and to comply with scheduled visits, treatment plan, and study related procedures
Understands and accepts the obligation and is logistically able to present for all scheduled follow-up visits.
Willing and able to comply with the protocol, including follow-up visits, examinations as well as having the ability to self-report pain and fatigue using a Patient-Reported Outcome (PRO) instrument
Patients who are able and willing to give consent and able to attend all study visits
201 Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.
Patients who are not able to comply with study and/or followup procedures
Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests and other study procedures
Willing and able to comply with scheduled visits, treatment plan and laboratory tests
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Ability and capacity to comply with study and follow-up procedures
Subject agrees to comply with follow-up procedures, including returning for all follow-up visits
Ability to understand study procedures and to comply with them for the entire length of the study
Must be able to comply with follow up visits
Willing and able to comply with all aspects of study procedures
Be willing and able to adhere to all study-related procedures
Able and willing to comply with all study related procedures
Willing and able to undergo study assessment
Willing to comply with study procedures and reporting requirements
Not willing to comply with study procedures and reporting requirements
Subject is willing and able to comply with the follow-up regimen
Subject is willing and able to meet study requirements, including follow up visits
Willing to comply with all study procedures and be available for the duration of the study.
Participant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCT
Participant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCT
Willing to comply with study procedures and reporting requirements
Not willing to comply with study procedures and reporting requirements
Participant must be willing to comply with study and/or follow-up procedures, including willingness to be followed for one year post-HCT
Patients must be willing to comply with the study procedures and visits
Subjects, who in the opinion of the investigator, may not be able to comply with study procedures
Have visits planned with the oncology physician for at least 3 months and be willing to come in for study visits
Be able to understand study procedures and comply with them for the entire length of the study period
Ability to understand and comply with study procedures for the entire length of the study
Participant is willing and able to comply with the protocol for the duration of the study including undergoing treatment, scheduled visits, and examinations
Ability to comply with study procedures for the entire length of the study
Be willing and able to comply with the treatment plan, scheduled clinic visits, laboratory tests and other study procedures
The subject is able to complete the study and comply with study instructions, including attending all study visits
Is willing and able to comply with study instructions and commit to all clinic visits for the duration of the study
Subject is willing and able to provide written informed consent. 5. Subject is willing and able to meet all study requirements, including follow-up visits and receiving study-related telephone calls.
Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, tumor biopsies, and other requirements of the study
Subject is willing and able to comply with all protocol required visits and assessments;
Patients must be deemed able to comply with the treatment plan and follow-up schedule
Participants must be willing and able to comply with scheduled visits and imaging procedures in the opinion of the investigator or treating physician
Any patients who are unable to comply with the study procedures as determined by the study investigators
Ability to understand and comply with study guidelines
Investigator has concerns regarding the ability of the subject to give written informed consent and/or to comply with study procedures (including availability for follow up visits).
Subject is willing and able to comply with all aspects of the treatment and evaluation schedule.
The subject is willing and able to comply with the study protocol
Ability to understand study procedures and to comply with them for the entire length of the study
The subject is willing to comply with 30-day follow-up in the office and answer quality-of-life questionnaires per protocol
The subject is willing to comply with 90-day follow-up by phone
The subject is not willing to comply with 60-day follow-up in the office and answer quality-of-life questionnaires per protocol
The subject is not willing to comply with 90-day follow-up by phone
Subject agrees to comply with the study requirements and agrees to come to the clinic for required study visits
Willingness to comply with all study interventions of acupuncture and follow-up assessments
Participant is willing to be randomized and able to comply with the protocol
Willingness and ability to sign an IRB/IEC approved ICF before performance of any study specific procedures or tests and to comply with protocol visits, and study procedures.
Willing and able to comply with trial protocol and follow-up
Willingness to comply with study guidelines
Willing and able to comply with trial protocol and follow-up
Willingness to comply with all study interventions and follow-up procedures
Willing and able to comply with trial protocol and follow-up
RECIPIENT: Participant must be willing to comply with study and/or follow?up procedures, including willingness to be followed for one year post?HCT
Willingness to comply with all study interventions and follow-up procedures including the ability to apply the study drug to the breast
Willing to complete all study visits
Willing and able to comply with trial protocol and follow-up
Willingness to comply with all treatment and follow up procedures
Subjects, who, in the opinion of the clinical Investigator, are able to understand this clinical investigation, cooperate with the investigational procedures and are willing to return for all the required post-treatment follow-up visits
Subjects who are willing to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Participant is willing to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
Patient is willing and able to give consent attend all study visits and complete all questionnaires as defined in the protocol
Subject is willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up
As determined by the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study
Willingness to comply with all study interventions and follow-up procedures including the ability to swallow the study drug
Willingness to comply with study guidelines
Willing to complete all study visits
Patients who are not able to comply with study and/or follow-up procedures
Stated willingness to comply with all required (non-optional) study procedures and be available for the duration of the study
Be willing and able to comply with scheduled visits, treatment plan, and MR imaging
Be conscious and able to comply with study procedures
Subject must be willing to comply with all clinical study procedures
Willingness to comply with the study protocol
Willing to comply with all study procedures and be available for the duration of the study
Subjects must be willing and able to comply with all procedures and visits required for this protocol (pre-treatment, during treatment, and post-treatment)
PATIENT: Be able to comply with study procedures
Subject deemed unlikely to be able to comply with instructions during imaging
Patients must be willing and able to be compliant with all procedures and visits required for this protocol (pre-treatment, during treatment, and optionally throughout follow-up period)
Willing and able to comply with scheduled visits and serial imaging procedures
Ability and willingness to comply with the study procedures
Able to understand, follow written instruction and willing to participate in all visits without rescheduled more than one or missed a visit without cancellation or rescheduling (no show)
Are willing and able to complete all procedures and assessments in accordance with the clinical protocol; and,
Must be able to understand and comply with study procedures for the entire length of the study
Willing to comply with all study procedures and be available for the duration of the study.
Patient is not likely to comply with the follow-up evaluation schedule
Able to provide written informed consent, comply with protocol visits and procedures, be able to take oral medication, and not have any active infection or comorbidity that would interfere with therapy.
Participants must be willing and able to comply with the study scheduled visits, laboratory tests, and other procedures outlined in the protocol.
Ability and willingness to comply with all study requirements, including scheduled visits, treatment plans, laboratory tests, and other study-related procedures
Patients who are unable to comply with study and/or follow up procedures
The patient is willing and able to comply with the study protocol
Be capable of providing informed consent and demonstrate a willingness to comply with all the study procedures and visits
Eligible subjects must be able and willing to undergo the procedures of the study
Be willing and able to comply with scheduled visits and other trial procedures
Willing and able to undergo all study procedures
Be willing and able to comply with scheduled visits and other trial procedures
Willing and able to comply with all aspects of the protocol.
Capable and willing to comply with the entire study protocol
Patients not able to comply with the study procedures
Able to comply with protocol visits and procedures
Are willing and able to comply with study procedures and instructions, including completion of diaries.
Willing and able to comply with all study procedures
Patient is not likely to comply with the follow-up evaluation schedule
Able and willing to follow study procedures and instructions.
Limitation of the patient's ability to comply with the treatment or follow-up protocol.
Able and willing to follow study procedures and instructions.
Available for all study visits and able to comply with all study requirements.
Subjects must be able and willing to follow study procedures and instructions.
Able and willing to complete the entire study
Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.
Subjects unable to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures
Willingness and ability to comply with the trial and follow-up procedures.
Subject likely to not be available to complete all protocol-required study visits or procedures, and/or to comply with all required study procedures to the best of the subject and investigator's knowledge.
Patient must be able to take oral medication and comply with protocol procedures and scheduled visits
Able and willing to complete the entire study
Participants must be willing and able to comply with all aspects of the protocol.
Note: Abstinence is acceptable if this is the usual lifestyle and preferred contraception for the subject; as determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
Willingness and ability to comply with study procedures
As determined by the enrolling physician or protocol designee, ability of the patient to understand and comply with study procedures for the entire length of the study
